CALPODD CV 325 | Cefpodoxime & Potassium Clavulanate Tablets

CALPODD CV 325 is a powerful synergistic antibiotic combination consisting of Cefpodoxime Proxetil (200 mg) and Potassium Clavulanate (125 mg).

While Cefpodoxime is a high-efficacy third-generation cephalosporin, many bacteria produce enzymes (beta-lactamases) that can deactivate it. The addition of Potassium Clavulanate (a beta-lactamase inhibitor) prevents this deactivation, making CALPODD CV 325 highly effective even against resistant bacterial strains.

Uses

CALPODD CV 325 is primarily prescribed for severe or recurrent infections:

• Upper Respiratory Tract Infections:Acute sinusitis, tonsillitis, and pharyngitis.

• Lower Respiratory Tract Infections:Community-acquired pneumonia and acute exacerbations of chronic bronchitis.

• Urinary Tract Infections (UTIs):Cystitis and kidney infections (pyelonephritis).

• Skin and Soft Tissue Infections:Cellulitis, abscesses, and infected wounds.

• Otitis Media:Acute infections of the middle ear, especially in cases where standard antibiotics have failed.

Benefits

• Overcomes Resistance:Effectively treats "superbugs" that produce beta-lactamase enzymes.

• Broad Spectrum:Provides comprehensive coverage against both Gram-positive and Gram-negative bacteria.

• High Success Rate:Offers a higher clinical cure rate in chronic and recurring infections compared to plain Cefpodoxime.

• Enhanced Stability:Designed to maintain therapeutic efficacy throughout the treatment course.

Side Effects

Commonly reported side effects are usually mild and may include:

• Diarrhea or loose stools (most common)

• Nausea or vomiting

• Abdominal pain

• Skin rashes or hives

• Oral thrush or vaginal yeast infection (due to prolonged use)